View PHARMExcel welcomes new MHRA Corporate Plan 2023-2026

PHARMExcel welcomes new MHRA Corporate Plan 2023-2026

PHARMExcel welcomes new risk-proportionate regulations and priority regulatory pathways in MHRA Corporate Plan 2023-2026

Read More

View Collaboration is Key – Learnings from UKCRF Network’s 18th Annual Conference

Collaboration is Key – Learnings from UKCRF Network’s 18th Annual Conference

Learn how collaboration is key to accelerating research to clinical trial stage and other key insights from the UK CRFN conference

Read More

View PHARMExcel joins forces with BIA to expand biotech horizons

PHARMExcel joins forces with BIA to expand biotech horizons

PHARMExcel joins forces with the BIA.

Read More

View PHARMExcel to attend UKCRFN Annual Conference 2023

PHARMExcel to attend UKCRFN Annual Conference 2023

Read More

View Case study: Liver dialysis device, DIALIVE, proves safe and effective

Case study: Liver dialysis device, DIALIVE, proves safe and effective

Read More

View PHARMExcel announces publication of its COV-BOOST paper in Journal of Infection

PHARMExcel announces publication of its COV-BOOST paper in Journal of Infection

We’re proud of our vital vaccine trial work, leading the way in prevention and control of infectious diseases

Read More

View Secukinumab in Behcet’s Trial: Working Towards a Promising Breakthrough for a Rare Autoimmune Condition

Secukinumab in Behcet’s Trial: Working Towards a Promising Breakthrough for a Rare Autoimmune Condition

Read More

View Proud to announce we are ISO 9001 certified!

Proud to announce we are ISO 9001 certified!

PHARMExcel CRO awarded ISO 9001:2015 quality management standard by the International Standards Organisation.

Read More

View PHARMExcel appoints Russell Wheatcroft as Chief Operating Officer

PHARMExcel appoints Russell Wheatcroft as Chief Operating Officer

We are delighted to announce the appointment of Russell Wheatcroft as Chief Operating Officer of PHARMExcel

Read More

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7